Lv42
800 积分 2021-10-18 加入
Relapsing polychondritis: clinical updates and new differential diagnoses
30天前
已完结
Advancing personalised precision treatment for Still's disease based on molecular characteristics and disease progression
1个月前
已完结
Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
1个月前
已完结
Advancing personalised precision treatment for Still's disease based on molecular characteristics and disease progression
1个月前
已完结
Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
4个月前
已完结
Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses
4个月前
已关闭
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease
4个月前
已完结
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
4个月前
已完结
Recent advances and evolving concepts in Still's disease
1年前
已完结
Diagnosis and management of ANCA-associated vasculitis
1年前
已完结
皖公网安备34019202002308
